Literature DB >> 26655023

Insights from the Structure of Mycobacterium tuberculosis Topoisomerase I with a Novel Protein Fold.

Kemin Tan1, Nan Cao2, Bokun Cheng3, Andrzej Joachimiak4, Yuk-Ching Tse-Dinh5.   

Abstract

The DNA topoisomerase I enzyme of Mycobacterium tuberculosis (MtTOP1) is essential for the viability of the organism and survival in a murine model. This topoisomerase is being pursued as a novel target for the discovery of new therapeutic agents for the treatment of drug-resistant tuberculosis. In this study, we succeeded in obtaining a structure of MtTOP1 by first predicting that the C-terminal region of MtTOP1 contains four repeated domains that do not involve the Zn-binding tetracysteine motifs seen in the C-terminal domains of Escherichia coli topoisomerase I. A construct (amino acids A2-T704), MtTOP1-704t, that includes the N-terminal domains (D1-D4) and the first predicted C-terminal domain (D5) of MtTOP1 was expressed and found to retain DNA cleavage-religation activity and catalyze single-stranded DNA catenation. MtTOP1-704t was crystallized, and a structure of 2.52Å resolution limit was obtained. The structure of the MtTOP1 N-terminal domains has features that have not been observed in other previously available bacterial topoisomerase I crystal structures. The first C-terminal domain D5 forms a novel protein fold of a four-stranded antiparallel β-sheet stabilized by a crossing-over α-helix. Since there is only one type IA topoisomerase present in Mycobacteriaceae and related Actinobacteria, this subfamily of type IA topoisomerase may be required for multiple functions in DNA replication, transcription, recombination, and repair. The unique structural features observed for MtTOP1 may allow these topoisomerase I enzymes to carry out physiological functions associated with topoisomerase III enzyme in other bacteria.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  TB; TopA; crystallization; protein domains; protein fold

Mesh:

Substances:

Year:  2015        PMID: 26655023      PMCID: PMC4738035          DOI: 10.1016/j.jmb.2015.11.024

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  37 in total

1.  Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions.

Authors:  E Krissinel; K Henrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

2.  The Structural Biology Center 19ID undulator beamline: facility specifications and protein crystallographic results.

Authors:  Gerd Rosenbaum; Randy W Alkire; Gwyndaf Evans; Frank J Rotella; Krzystof Lazarski; Rong Guang Zhang; Stephan L Ginell; Norma Duke; Istvan Naday; Jack Lazarz; Michael J Molitsky; Lisa Keefe; John Gonczy; Larry Rock; Ruslan Sanishvili; Martin A Walsh; Edwin Westbrook; Andrzej Joachimiak
Journal:  J Synchrotron Radiat       Date:  2005-12-22       Impact factor: 2.616

3.  HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes.

Authors:  Wladek Minor; Marcin Cymborowski; Zbyszek Otwinowski; Maksymilian Chruszcz
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-07-18

4.  Inference of macromolecular assemblies from crystalline state.

Authors:  Evgeny Krissinel; Kim Henrick
Journal:  J Mol Biol       Date:  2007-05-13       Impact factor: 5.469

5.  The structure of Escherichia coli DNA topoisomerase III.

Authors:  A Mondragón; R DiGate
Journal:  Structure       Date:  1999-11-15       Impact factor: 5.006

6.  Crystal structure of full length topoisomerase I from Thermotoga maritima.

Authors:  Guido Hansen; Axel Harrenga; Bernd Wieland; Dietmar Schomburg; Peter Reinemer
Journal:  J Mol Biol       Date:  2006-03-23       Impact factor: 5.469

7.  Three-dimensional structure of the 67K N-terminal fragment of E. coli DNA topoisomerase I.

Authors:  C D Lima; J C Wang; A Mondragón
Journal:  Nature       Date:  1994-01-13       Impact factor: 49.962

Review 8.  Phylogenomics of DNA topoisomerases: their origin and putative roles in the emergence of modern organisms.

Authors:  Patrick Forterre; Danièle Gadelle
Journal:  Nucleic Acids Res       Date:  2009-02-09       Impact factor: 16.971

Review 9.  Bacterial topoisomerase I as a target for discovery of antibacterial compounds.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Nucleic Acids Res       Date:  2008-11-28       Impact factor: 16.971

10.  MolProbity: all-atom contacts and structure validation for proteins and nucleic acids.

Authors:  Ian W Davis; Andrew Leaver-Fay; Vincent B Chen; Jeremy N Block; Gary J Kapral; Xueyi Wang; Laura W Murray; W Bryan Arendall; Jack Snoeyink; Jane S Richardson; David C Richardson
Journal:  Nucleic Acids Res       Date:  2007-04-22       Impact factor: 16.971

View more
  15 in total

1.  Distinct Mechanism Evolved for Mycobacterial RNA Polymerase and Topoisomerase I Protein-Protein Interaction.

Authors:  Srikanth Banda; Nan Cao; Yuk-Ching Tse-Dinh
Journal:  J Mol Biol       Date:  2017-08-24       Impact factor: 5.469

2.  Crystal structure of the 65-kilodalton amino-terminal fragment of DNA topoisomerase I from the gram-positive model organism Streptococcus mutans.

Authors:  Jesse A Jones; Kirk E Hevener
Journal:  Biochem Biophys Res Commun       Date:  2019-06-14       Impact factor: 3.575

Review 3.  Collaborative drug discovery for More Medicines for Tuberculosis (MM4TB).

Authors:  Sean Ekins; Anna Coulon Spektor; Alex M Clark; Krishna Dole; Barry A Bunin
Journal:  Drug Discov Today       Date:  2016-11-22       Impact factor: 7.851

4.  Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.

Authors:  Rashmi Gupta; Carolina Rodrigues Felix; Matthew P Akerman; Kate J Akerman; Cathryn A Slabber; Wenjie Wang; Jessie Adams; Lindsey N Shaw; Yuk-Ching Tse-Dinh; Orde Q Munro; Kyle H Rohde
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

5.  A simplified protocol for high-yield expression and purification of bacterial topoisomerase I.

Authors:  Jesse A Jones; Emily Price; Donovan Miller; Kirk E Hevener
Journal:  Protein Expr Purif       Date:  2016-04-23       Impact factor: 1.650

6.  Mechanistic insights from structure of Mycobacterium smegmatis topoisomerase I with ssDNA bound to both N- and C-terminal domains.

Authors:  Nan Cao; Kemin Tan; Xiaobing Zuo; Thirunavukkarasu Annamalai; Yuk-Ching Tse-Dinh
Journal:  Nucleic Acids Res       Date:  2020-05-07       Impact factor: 16.971

7.  Illustrating and homology modeling the proteins of the Zika virus.

Authors:  Sean Ekins; John Liebler; Bruno J Neves; Warren G Lewis; Megan Coffee; Rachelle Bienstock; Christopher Southan; Carolina H Andrade
Journal:  F1000Res       Date:  2016-03-03

8.  Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays.

Authors:  Shayna Sandhaus; Prem P Chapagain; Yuk-Ching Tse-Dinh
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

9.  Amsacrine Derivatives Selectively Inhibit Mycobacterial Topoisomerase I (TopA), Impair M. smegmatis Growth and Disturb Chromosome Replication.

Authors:  Marcin J Szafran; Marta Kołodziej; Patrycja Skut; Brahmam Medapi; Agnieszka Domagała; Damian Trojanowski; Jolanta Zakrzewska-Czerwińska; Dharmarajan Sriram; Dagmara Jakimowicz
Journal:  Front Microbiol       Date:  2018-07-17       Impact factor: 5.640

10.  C-terminal lysine repeats in Streptomyces topoisomerase I stabilize the enzyme-DNA complex and confer high enzyme processivity.

Authors:  Agnieszka Strzalka; Marcin J Szafran; Terence Strick; Dagmara Jakimowicz
Journal:  Nucleic Acids Res       Date:  2017-11-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.